Cargando…

Dose‐finding methods for Phase I clinical trials using pharmacokinetics in small populations

The aim of phase I clinical trials is to obtain reliable information on safety, tolerability, pharmacokinetics (PK), and mechanism of action of drugs with the objective of determining the maximum tolerated dose (MTD). In most phase I studies, dose‐finding and PK analysis are done separately and no a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ursino, Moreno, Zohar, Sarah, Lentz, Frederike, Alberti, Corinne, Friede, Tim, Stallard, Nigel, Comets, Emmanuelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	General
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573988/ https://www.ncbi.nlm.nih.gov/pubmed/28321893 http://dx.doi.org/10.1002/bimj.201600084

Ejemplares similares

Recent advances in methodology for clinical trials in small populations: the InSPiRe project
por: Friede, Tim, et al.
Publicado: (2018)

Unified approach for extrapolation and bridging of adult information in early-phase dose-finding paediatric studies
por: Petit, Caroline, et al.
Publicado: (2016)

Using dichotomized survival data to construct a prior distribution for a Bayesian seamless Phase II/III clinical trial
por: Duputel, Benjamin, et al.
Publicado: (2023)

Bayesian dose regimen assessment in early phase oncology incorporating pharmacokinetics and pharmacodynamics
por: Gerard, Emma, et al.
Publicado: (2021)

Estimating Similarity of Dose–Response Relationships in Phase I Clinical Trials—Case Study in Bridging Data Package
por: Ollier, Adrien, et al.
Publicado: (2021)

Experimental designs for phase I and phase I/II dose-finding studies
por: O'quigley, J, et al.
Publicado: (2006)

Dose-finding designs for cumulative toxicities using multiple constraints
por: Lee, Shing M, et al.
Publicado: (2019)

Bayesian Approaches for Confirmatory Trials in Rare Diseases: Opportunities and Challenges
por: Ursino, Moreno, et al.
Publicado: (2021)

Bayesian treatment comparison using parametric mixture priors computed from elicited histograms
por: Thall, Peter F, et al.
Publicado: (2017)

A Bayesian non-inferiority approach using experts’ margin elicitation – application to the monitoring of safety events
por: Aupiais, Camille, et al.
Publicado: (2019)

Systematic reviews in paediatric multiple sclerosis and Creutzfeldt-Jakob disease exemplify shortcomings in methods used to evaluate therapies in rare conditions
por: Unkel, Steffen, et al.
Publicado: (2016)

Data-driven treatment selection for seamless phase II/III trials incorporating early-outcome data
por: Kunz, Cornelia Ursula, et al.
Publicado: (2014)

Levetiracetam optimal dose-finding as first-line treatment for neonatal seizures occurring in the context of hypoxic-ischaemic encephalopathy (LEVNEONAT-1): study protocol of a phase II trial
por: Favrais, Geraldine, et al.
Publicado: (2019)

Adaptive seamless clinical trials using early outcomes for treatment or subgroup selection: Methods, simulation model and their implementation in R
por: Friede, Tim, et al.
Publicado: (2020)

Flexible selection of a single treatment incorporating short‐term endpoint information in a phase II/III clinical trial
por: Stallard, Nigel, et al.
Publicado: (2015)

A Comparison of Methods for Treatment Selection in Seamless Phase II/III Clinical Trials Incorporating Information on Short-Term Endpoints
por: Kunz, Cornelia Ursula, et al.
Publicado: (2015)

Bayesian modeling of a bivariate toxicity outcome for early phase oncology trials evaluating dose regimens
por: Gerard, Emma, et al.
Publicado: (2021)

Phase I dose-escalation oncology trials with sequential multiple schedules
por: Günhan, Burak Kürsad, et al.
Publicado: (2021)

A phase I dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemia
por: Lévy, V, et al.
Publicado: (2006)

Full versus half dose of antenatal betamethasone to prevent severe neonatal respiratory distress syndrome associated with preterm birth: study protocol for a randomised, multicenter, double blind, placebo-controlled, non-inferiority trial (BETADOSE)
por: Schmitz, Thomas, et al.
Publicado: (2019)

Software tools for implementing simulation studies in adaptive seamless designs: introducing R package ASD
por: Parsons, Nick, et al.
Publicado: (2011)

Dose-Finding Study of Omeprazole on Gastric pH in Neonates with Gastro-Esophageal Acid Reflux Using a Bayesian Sequential Approach
por: Kaguelidou, Florentia, et al.
Publicado: (2016)

Blinded versus unblinded estimation of a correlation coefficient to inform interim design adaptations
por: Kunz, Cornelia U., et al.
Publicado: (2016)

A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors
por: Poveda, Andres, et al.
Publicado: (2021)

Spline-based procedures for dose-finding studies with active control
por: Helms, Hans-Joachim, et al.
Publicado: (2015)

Point and Interval Estimators of the Target Dose in Clinical Dose-Finding Studies with Active Control
por: Helms, H.-J., et al.
Publicado: (2015)

Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review
por: Ondra, Thomas, et al.
Publicado: (2016)

The Use of Translational Modelling and Simulation to Develop Immunomodulatory Therapy as an Adjunct to Antibiotic Treatment in the Context of Pneumonia
por: Michelet, Robin, et al.
Publicado: (2021)

Pharmacokinetics of ASP4345 from Single Ascending-Dose and Multiple Ascending-Dose Phase I Studies
por: Desai, Amit, et al.
Publicado: (2020)

Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours
por: Evans, T. R. Jeffry, et al.
Publicado: (2019)

Riluzole for treating spasticity in patients with chronic traumatic spinal cord injury: Study protocol in the phase ib/iib adaptive multicenter randomized controlled RILUSCI trial
por: Cotinat, Maëva, et al.
Publicado: (2023)

Bayesian variable selection based on clinical relevance weights in small sample studies—Application to colon cancer
por: Boulet, Sandrine, et al.
Publicado: (2019)

Identification of subgroup effect with an individual participant data meta-analysis of randomised controlled trials of three different types of therapist-delivered care in low back pain
por: Hee, Siew Wan, et al.
Publicado: (2021)

Combined Analysis of Phase I and Phase II Data to Enhance the Power of Pharmacogenetic Tests
por: Tessier, A, et al.
Publicado: (2016)

An adaptive seamless phase II/III clinical trial design incorporating short-term endpoint information
por: Stallard, Nigel
Publicado: (2011)

An adaptive power prior for sequential clinical trials – Application to bridging studies
por: Ollier, Adrien, et al.
Publicado: (2019)

Pharmacokinetics of multiple doses of co‐crystal of tramadol–celecoxib: findings from a four‐way randomized open‐label phase I clinical trial
por: Videla, Sebastián, et al.
Publicado: (2017)

Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies
por: Brada, M, et al.
Publicado: (1999)

Phase I dose-escalation and pharmacokinetic study of a novel folate analogue AG2034
por: Bissett, D, et al.
Publicado: (2001)

Phase I study of single‐dose pharmacokinetics and pharmacodynamics of belatacept in adolescent kidney transplant recipients
por: Moudgil, Asha, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8sp8o2l087dq3km0s5ssocarc9